A line of defense is emerging for top prescription drug companies whose topexecutives will be pulled before Congress on Tuesday to testify about high prices for medicine: They are not to blame.
Laura Lucero Y Ruiz De Gutierrez has a heart condition and fibromyalgia and is in danger of developing diabetes. She has health insurance through her husband’s job. But, between the $800 monthly premium for the couple’s coverage and the $2,100 deductible she has to pay down before insurance starts picking up the tab, she doesn’t feel she can afford to go to the doctor when she needs to.
There is increasingly a push for benefit advisers to bring new technology to clients, but they may need to be more strategic when using it.
California would become the first state to block pharmaceutical companies from paying generic competitors to delay the release of lower-priced drugs under a bill announced Wednesday.
Even before Democrats finish drafting bills to create a single-payer health care system, the health care and insurance industries have assembled a small army of lobbyists to kill “Medicare for all,” an idea that is mocked publicly but is being greeted privately with increasing seriousness.
Disease-specific efforts targeting cancer research and efforts to curb HIV in the U.S. will be among the priorities for the Department of Health and Human Services in the year ahead, Secretary Alex Azar said in a speech on Friday.
Two top U.S. senators launched an investigation into rising insulin prices on Friday, sending letters to the three leading manufacturers seeking answers as to why the nearly 100-year-old drug’s cost has rapidly risen, causing taxpayers to spend millions of dollars a year.
When it comes to making changes in health care, CVS Health isn't settling for tinkering around the edges. The company is looking to strike at the heart of how health care is delivered in the U.S.
The Affordable Care Act public exchange system is making a change that could help some people avoid tax nightmares but cause some other people to suffer a sudden, unexpected loss of ACA exchange plan health coverage.
Cigna Corp. officials did everything they could to sabotage a $48.9 billion merger with Anthem Inc., including refusing to consider divestitures that would have helped the deal win regulatory approval, Anthem’s general counsel told a judge.